[Clinical pharmacology in obstetrics: regulation of the uterus].
D000318:Adrenergic beta-Agonists / Q000494:pharmacology / Q000627:therapeutic use; D001241:Aspirin / Q000031:analogs & derivatives / Q000494:pharmacology / Q000627:therapeutic use; D004878:Ergotamine / Q000494:pharmacology / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007213:Indomethacin / Q000031:analogs & derivatives / Q000494:pharmacology / Q000627:therapeutic use; D008755:Methylergonovine / Q000494:pharmacology / Q000627:therapeutic use; D007744:Obstetric Labor Complications / Q000188:drug therapy*; D007752:Obstetric Labor, Premature / Q000517:prevention & control; D010120:Oxytocics / Q000008:administration & dosage*; D010121:Oxytocin / Q000494:pharmacology / Q000627:therapeutic use; D010208:Papaverine / Q000031:analogs & derivatives / Q000494:pharmacology / Q000627:therapeutic use; D011247:Pregnancy; D011248:Pregnancy Complications / Q000188:drug therapy*; D011453:Prostaglandins / Q000494:pharmacology / Q000627:therapeutic use; D014590:Uterine Contraction / Q000187:drug effects*; D014599:Uterus / Q000187:drug effects
D000318:Adrenergic beta-Agonists; D010120:Oxytocics; D011453:Prostaglandins; D010121:Oxytocin; D010208:Papaverine; D004878:Ergotamine; D001241:Aspirin; D008755:Methylergonovine; D007213:Indomethacin
Klinische Pharmakologie in der Geburtshilfe: Uterusregulation